What motivates adults to accept influenza vaccine? An assessment of incentives, ease of access, messaging, and sources of information using a discrete choice experiment.
Adults
Discrete choice experiment
Influenza vaccine
Vaccine confidence
Vaccine demand
Journal
SSM - population health
ISSN: 2352-8273
Titre abrégé: SSM Popul Health
Pays: England
ID NLM: 101678841
Informations de publication
Date de publication:
Jun 2023
Jun 2023
Historique:
received:
03
11
2022
revised:
10
03
2023
accepted:
13
03
2023
medline:
4
4
2023
entrez:
3
4
2023
pubmed:
4
4
2023
Statut:
epublish
Résumé
Seasonal influenza vaccination rates remain low, and contribute to preventable influenza cases, hospitalizations, and deaths in the US. While numerous interventions have been implemented to increase vaccine uptake, there is a need to determine which interventions contribute most to vaccine willingness, particularly among age groups with vaccination rates that have plateaued at suboptimal levels. This study aimed to quantify the relative effect of multiple interventions on vaccine willingness to receive influenza vaccine in three age groups using a series of hypothetical situations with different behavioral interventions. We assessed the relative impact of four categories of interventions: source of vaccine messages, type of vaccination messages, vaccination incentives, and ease of vaccine access using a discrete choice experiment. Within each category, we investigated the role of four different attributes to measure their relative contribution to willingness to be vaccinated by removing one option from each of the intervention categories. Among the 1,763 Minnesota residents who volunteered for our study, participants expressed vaccine willingness in over 80% of the scenarios presented. Easy access to drop-in vaccination sites had the greatest impact on vaccine willingness in all age groups. Among the younger age group, small financial incentives also contributed to high vaccine willingness. Our results suggest that public health programs and vaccination campaigns may improve their chances of successfully increasing vaccine willingness if they offer interventions preferred by adults, including facilitating convenient access to vaccination and offering small monetary incentives, particularly for young adults.
Identifiants
pubmed: 37008807
doi: 10.1016/j.ssmph.2023.101384
pii: S2352-8273(23)00049-6
pmc: PMC10060740
doi:
Types de publication
Journal Article
Langues
eng
Pagination
101384Informations de copyright
© 2023 The Authors.
Déclaration de conflit d'intérêts
The authors declare that the funders had no role in the role in the design of the study or in the analysis and interpretation of data.
Références
Health Econ. 2011 Mar;20(3):273-86
pubmed: 20143304
Vaccine. 2016 May 23;34(24):2671-8
pubmed: 27118168
Health Econ Rev. 2022 Aug 2;12(1):41
pubmed: 35917007
Vaccine. 2019 Apr 3;37(15):2079-2089
pubmed: 30857931
Rev Econ Stat. 2012 May 1;94(2):580-595
pubmed: 22544977
Science. 2021 Nov 12;374(6569):879-882
pubmed: 34618594
BMJ Open. 2017 Sep 25;7(9):e017459
pubmed: 28951412
Patient. 2017 Dec;10(6):687-700
pubmed: 28474295
Br J Soc Psychol. 1998 Jun;37 ( Pt 2):151-65
pubmed: 9639861
Vaccine. 2014 Sep 3;32(39):5071-6
pubmed: 25063570
Ann N Y Acad Sci. 2011 Oct;1235:57-74
pubmed: 22023568
PLoS One. 2017 Jan 26;12(1):e0170550
pubmed: 28125629
Value Health. 2016 Jun;19(4):300-15
pubmed: 27325321
Health Psychol. 2007 Mar;26(2):136-45
pubmed: 17385964
Soc Sci Med. 2007 Apr;64(8):1738-53
pubmed: 17257725
J Environ Manage. 2016 Dec 1;183:98-109
pubmed: 27576151
Vaccine. 2018 Jun 22;36(27):3960-3966
pubmed: 29801998
Hum Vaccin Immunother. 2019;15(5):1080-1091
pubmed: 30735474
Value Health. 2011 Jun;14(4):403-13
pubmed: 21669364
Clin Infect Dis. 2020 Jun 10;70(12):2496-2502
pubmed: 31344229
Vaccine. 2017 May 9;35(20):2676-2684
pubmed: 28408120
Int J Environ Res Public Health. 2018 Apr 10;15(4):
pubmed: 29642624
Proc Natl Acad Sci U S A. 2015 Dec 8;112(49):E6725-6
pubmed: 26598650
Epidemiol Infect. 1997 Dec;119(3):335-41
pubmed: 9440437
Vaccine. 2018 Mar 7;36(11):1467-1476
pubmed: 29426662
Value Health. 2019 Feb;22(2):157-160
pubmed: 30711059
PLoS One. 2018 Dec 7;13(12):e0208601
pubmed: 30532274
Int J Nurs Stud. 2019 Mar;91:144-145
pubmed: 29958670
Sci Rep. 2021 May 26;11(1):11025
pubmed: 34040014
Value Health. 2020 Feb;23(2):200-208
pubmed: 32113625
Int J Epidemiol. 2014 Jun;43(3):962-70
pubmed: 24603316
PLoS One. 2022 May 24;17(5):e0268911
pubmed: 35609052
BMJ Glob Health. 2021 Sep;6(9):
pubmed: 34593513
SSM Popul Health. 2017 Nov 14;4:25-36
pubmed: 29349270
BMC Public Health. 2013 Apr 25;13:388
pubmed: 23617788
PLoS One. 2021 Aug 20;16(8):e0256394
pubmed: 34415928
Cochrane Database Syst Rev. 2018 May 30;5:CD005188
pubmed: 29845606
Eur J Health Econ. 2018 Nov;19(8):1053-1066
pubmed: 29380229
Euro Surveill. 2016 Jun 2;21(22):
pubmed: 27277581
Health Econ. 2012 Jun;21(6):730-41
pubmed: 21557381
MMWR Surveill Summ. 2017 May 05;66(11):1-28
pubmed: 28472027
Psychol Sci Public Interest. 2017 Dec;18(3):149-207
pubmed: 29611455
J Natl Med Assoc. 2004 Nov;96(11):1455-61
pubmed: 15586649
BMC Med Res Methodol. 2016 Apr 21;16:45
pubmed: 27098746
Vaccine. 2019 Feb 21;37(9):1168-1173
pubmed: 30709722
Acad Pediatr. 2021 May-Jun;21(4S):S9-S16
pubmed: 33958099
Vaccine. 2015 Jun 4;33(24):2741-56
pubmed: 25936726
Cochrane Database Syst Rev. 2018 Jan 18;1:CD003941
pubmed: 29342498
Am J Trop Med Hyg. 2015 Feb;92(2):233-237
pubmed: 25510724
PLoS One. 2014 Jul 24;9(7):e102505
pubmed: 25057914
Euro Surveill. 2022 Apr;27(17):
pubmed: 35485271
Vaccine. 2010 Sep 24;28(41):6692-7
pubmed: 20708696
Clin Infect Dis. 2019 Apr 24;68(9):1444-1453
pubmed: 30307490
BMC Pulm Med. 2017 May 3;17(1):79
pubmed: 28468650